nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS1—malignant glioma	0.606	0.636	CbGaD
Lornoxicam—PTGS2—malignant glioma	0.346	0.364	CbGaD
Lornoxicam—Tenoxicam—PTGS1—malignant glioma	0.00214	0.273	CrCbGaD
Lornoxicam—Meloxicam—PTGS1—malignant glioma	0.00152	0.195	CrCbGaD
Lornoxicam—Piroxicam—PTGS1—malignant glioma	0.00132	0.169	CrCbGaD
Lornoxicam—Tenoxicam—PTGS2—malignant glioma	0.00122	0.156	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—malignant glioma	0.00087	0.111	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—malignant glioma	0.000755	0.0964	CrCbGaD
Lornoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000263	0.00652	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000259	0.0064	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000256	0.00634	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000256	0.00633	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000254	0.00628	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00024	0.00594	CbGpPWpGaD
Lornoxicam—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000237	0.00587	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000231	0.00571	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000224	0.00555	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000224	0.00554	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000222	0.00549	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000222	0.00549	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.00022	0.00545	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000212	0.00524	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000209	0.00517	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.000203	0.00503	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000199	0.00493	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.000181	0.00449	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000177	0.00437	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000175	0.00433	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000175	0.00432	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000168	0.00416	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000166	0.00411	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.000164	0.00405	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.000163	0.00403	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00016	0.00397	CbGpPWpGaD
Lornoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000159	0.00394	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000153	0.0038	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	0.000153	0.00379	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000152	0.00377	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000145	0.00359	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000143	0.00354	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000136	0.00336	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000136	0.00336	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	0.000135	0.00333	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000134	0.00332	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	0.000129	0.00319	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	0.000129	0.00319	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—RTEL1—malignant glioma	0.000127	0.00315	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTP1—malignant glioma	0.000126	0.00311	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000124	0.00307	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	0.000122	0.00301	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000118	0.00292	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000117	0.00289	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000116	0.00288	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	0.000116	0.00287	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000111	0.00275	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	0.00011	0.00272	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000108	0.00266	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000105	0.0026	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	0.000104	0.00256	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—RTEL1—malignant glioma	0.000101	0.0025	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.0001	0.00248	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	9.94e-05	0.00246	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	9.81e-05	0.00243	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	9.65e-05	0.00239	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	9.64e-05	0.00239	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTT1—malignant glioma	9.53e-05	0.00236	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	9.37e-05	0.00232	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	9.21e-05	0.00228	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	9.2e-05	0.00228	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.08e-05	0.00225	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	8.97e-05	0.00222	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—PTGS1—malignant glioma	8.93e-05	0.00221	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	8.89e-05	0.0022	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.79e-05	0.00218	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	8.22e-05	0.00203	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	8.07e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	7.51e-05	0.00186	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—COX8A—malignant glioma	7.3e-05	0.00181	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	7.29e-05	0.0018	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	7.21e-05	0.00179	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.21e-05	0.00178	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.98e-05	0.00173	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	6.78e-05	0.00168	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—RTEL1—malignant glioma	6.68e-05	0.00165	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	6.65e-05	0.00165	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTP1—malignant glioma	6.61e-05	0.00164	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	6.52e-05	0.00161	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	6.5e-05	0.00161	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	6.49e-05	0.00161	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL2—malignant glioma	6.48e-05	0.0016	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	6.46e-05	0.0016	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	6.26e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ASMT—malignant glioma	6.21e-05	0.00154	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6.19e-05	0.00153	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	6.14e-05	0.00152	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	6.13e-05	0.00152	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.06e-05	0.0015	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	5.96e-05	0.00148	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BCAN—malignant glioma	5.83e-05	0.00144	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—COX8A—malignant glioma	5.79e-05	0.00143	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BCAN—malignant glioma	5.53e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.27e-05	0.0013	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.18e-05	0.00128	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MYC—malignant glioma	5.06e-05	0.00125	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5e-05	0.00124	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—DTX1—malignant glioma	5e-05	0.00124	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	4.95e-05	0.00123	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.93e-05	0.00122	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ASMT—malignant glioma	4.93e-05	0.00122	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.91e-05	0.00122	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.86e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.81e-05	0.00119	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.77e-05	0.00118	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNF—malignant glioma	4.72e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—IDH2—malignant glioma	4.7e-05	0.00116	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BCAN—malignant glioma	4.63e-05	0.00115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.62e-05	0.00114	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.43e-05	0.0011	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP2B6—malignant glioma	4.42e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.41e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TP53—malignant glioma	4.16e-05	0.00103	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.14e-05	0.00103	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—IDH1—malignant glioma	4.04e-05	0.001	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HEY2—malignant glioma	3.92e-05	0.000972	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SPHK1—malignant glioma	3.91e-05	0.000969	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—COX8A—malignant glioma	3.84e-05	0.00095	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP2C18—malignant glioma	3.83e-05	0.000949	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IDH1—malignant glioma	3.83e-05	0.000949	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.74e-05	0.000927	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—IDH2—malignant glioma	3.73e-05	0.000924	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HEY1—malignant glioma	3.63e-05	0.0009	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.61e-05	0.000895	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HIST1H3B—malignant glioma	3.53e-05	0.000874	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.52e-05	0.000871	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2B6—malignant glioma	3.51e-05	0.000869	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.44e-05	0.000853	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.43e-05	0.000849	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.37e-05	0.000834	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.29e-05	0.000815	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ASMT—malignant glioma	3.26e-05	0.000808	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAG2—malignant glioma	3.22e-05	0.000798	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—IDH1—malignant glioma	3.21e-05	0.000795	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.21e-05	0.000794	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.19e-05	0.000789	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.18e-05	0.000788	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.18e-05	0.000787	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SPHK1—malignant glioma	3.11e-05	0.000769	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTT1—malignant glioma	3.1e-05	0.000768	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BCAN—malignant glioma	3.07e-05	0.000759	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2C18—malignant glioma	3.04e-05	0.000753	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.92e-05	0.000724	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.89e-05	0.000717	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.87e-05	0.00071	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.83e-05	0.0007	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—H3F3A—malignant glioma	2.73e-05	0.000675	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BCHE—malignant glioma	2.7e-05	0.000669	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC5A5—malignant glioma	2.67e-05	0.00066	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.61e-05	0.000647	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAG1—malignant glioma	2.57e-05	0.000636	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.52e-05	0.000625	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.52e-05	0.000625	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FBXW7—malignant glioma	2.52e-05	0.000624	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.5e-05	0.000619	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—IDH2—malignant glioma	2.47e-05	0.000612	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTT1—malignant glioma	2.46e-05	0.000609	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.39e-05	0.000591	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.33e-05	0.000577	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.32e-05	0.000575	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTGS1—malignant glioma	2.31e-05	0.000571	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.3e-05	0.000569	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.18e-05	0.00054	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—malignant glioma	2.15e-05	0.000532	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BCHE—malignant glioma	2.14e-05	0.000531	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—IDH1—malignant glioma	2.13e-05	0.000526	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC5A5—malignant glioma	2.12e-05	0.000524	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAT—malignant glioma	2.09e-05	0.000518	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SPHK1—malignant glioma	2.06e-05	0.000509	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.02e-05	0.000499	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2e-05	0.000496	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOR1—malignant glioma	1.97e-05	0.000489	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN2B—malignant glioma	1.97e-05	0.000489	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.9e-05	0.00047	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HES1—malignant glioma	1.88e-05	0.000466	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCOR1—malignant glioma	1.87e-05	0.000463	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFRA—malignant glioma	1.79e-05	0.000444	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.73e-05	0.000429	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.73e-05	0.000428	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—malignant glioma	1.71e-05	0.000422	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.67e-05	0.000414	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAT—malignant glioma	1.66e-05	0.000411	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HLA-A—malignant glioma	1.65e-05	0.000408	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TERT—malignant glioma	1.65e-05	0.000408	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTT1—malignant glioma	1.63e-05	0.000403	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFB—malignant glioma	1.61e-05	0.000399	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAV1—malignant glioma	1.61e-05	0.000399	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR1—malignant glioma	1.6e-05	0.000397	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HIF1A—malignant glioma	1.58e-05	0.000391	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOR1—malignant glioma	1.57e-05	0.000388	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.54e-05	0.000381	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS1—malignant glioma	1.53e-05	0.000378	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CAV1—malignant glioma	1.53e-05	0.000378	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.52e-05	0.000377	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CG—malignant glioma	1.47e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BAD—malignant glioma	1.44e-05	0.000355	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOTCH1—malignant glioma	1.42e-05	0.000352	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BCHE—malignant glioma	1.42e-05	0.000352	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARG—malignant glioma	1.42e-05	0.00035	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.4e-05	0.000347	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD80—malignant glioma	1.39e-05	0.000345	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APC—malignant glioma	1.39e-05	0.000344	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGF—malignant glioma	1.37e-05	0.00034	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTPN11—malignant glioma	1.37e-05	0.000338	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.33e-05	0.000328	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.31e-05	0.000325	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BRAF—malignant glioma	1.31e-05	0.000323	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CD—malignant glioma	1.29e-05	0.000319	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAV1—malignant glioma	1.28e-05	0.000316	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT2—malignant glioma	1.27e-05	0.000315	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CD—malignant glioma	1.22e-05	0.000303	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.22e-05	0.000302	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF2—malignant glioma	1.17e-05	0.00029	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CG—malignant glioma	1.16e-05	0.000288	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.15e-05	0.000284	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—malignant glioma	1.13e-05	0.00028	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CB—malignant glioma	1.12e-05	0.000278	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARG—malignant glioma	1.12e-05	0.000278	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—malignant glioma	1.11e-05	0.000276	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAT—malignant glioma	1.1e-05	0.000272	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MDM2—malignant glioma	1.09e-05	0.000271	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RAF1—malignant glioma	1.09e-05	0.00027	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB2—malignant glioma	1.08e-05	0.000267	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CB—malignant glioma	1.07e-05	0.000264	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOR1—malignant glioma	1.04e-05	0.000257	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CD—malignant glioma	1.02e-05	0.000253	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—malignant glioma	9.71e-06	0.00024	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—malignant glioma	9.2e-06	0.000228	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CB—malignant glioma	8.92e-06	0.000221	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAV1—malignant glioma	8.46e-06	0.00021	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT3—malignant glioma	8.23e-06	0.000204	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.09e-06	0.0002	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.71e-06	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—malignant glioma	7.71e-06	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—malignant glioma	7.65e-06	0.000189	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGFR—malignant glioma	7.48e-06	0.000185	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARG—malignant glioma	7.44e-06	0.000184	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KRAS—malignant glioma	7.07e-06	0.000175	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CA—malignant glioma	6.85e-06	0.00017	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.78e-06	0.000168	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CA—malignant glioma	6.49e-06	0.000161	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.91e-06	0.000146	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—malignant glioma	5.85e-06	0.000145	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKT1—malignant glioma	5.6e-06	0.000139	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CA—malignant glioma	5.44e-06	0.000135	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT1—malignant glioma	5.3e-06	0.000131	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—malignant glioma	5.1e-06	0.000126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKT1—malignant glioma	4.44e-06	0.00011	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.6e-06	8.91e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKT1—malignant glioma	2.94e-06	7.28e-05	CbGpPWpGaD
